European alliance to advance proximity-induced drug modalities
- grebner0
- 2 days ago
- 1 min read
Updated: 4 hours ago
Scientists from leading European research institutions, Goethe University Frankfurt, IRB Barcelona, AITHYRA in Vienna, the University of Dundee, and EPFL Lausanne, propose the creation of a European Alliance to accelerate the development of proximity-induced drug modalities. This was published by PROXIDRUGS speaker Ivan Đikić and his coauthors in a Perspective in Molecular Cell.
Proximity-inducing drugs aim to harness the concept of bringing molecules into close proximity to target disease-relevant proteins, many of which are currently considered undruggable. The now published Perspective outlines recent scientific breakthroughs and emphasizes the foundational role of academia in advancing this field and call for tighter academic-industry collaboration to unlock its full therapeutic potential.
The Authors urge the formation of a global academic–industry alliance to share resources, accelerate early-stage drug discovery, and train the next generation of scientists, ensuring faster translation of breakthroughs to the clinic.
